transforming growth factor β1 (tgf-β1) in the sera of postmenopausal osteoporotic females

نویسندگان

aazam faraji department of obstetrics and gynecology, school of medicine, shiraz, iran

shabnam abtahi shiraz institute for cancer research, school of medicine, shiraz university of medical sciences, shiraz, iran

abbas ghaderi shiraz institute for cancer research, school of medicine, shiraz university of medical sciences, shiraz, iran

alamtaj samsami dehaghani department of obstetrics and gynecology, school of medicine, shiraz, iran; department of obstetrics and gynecology, school of medicine, shiraz, iran

چکیده

conclusions our study demonstrated that tgf-β1 serum levels is higher in osteoporotic postmenopausal females than non-osteoporotic ones, and probably aberrant increase in tgf-β1 in postmenopausal females can result in uncoupled bone resorption and formation, which leads to osteoporosis. background postmenopausal osteoporosis is a major cause of morbidity in postmenopausal females. transforming growth factor β1 (tgf-β1) and interleukin 18 (il-18) play complex roles in normal bone metabolism, and in pathophysiology of postmenopausal osteoporosis. objectives the aim of this study was to design an analytic cross sectional study in order to further clarify the role of tgf-β1 and il-18 in osteoporosis of postmenopausal females. methods a cross sectional study including 65 postmenopausal osteoporotic females as cases and 69 postmenopausal females of similar age without osteoporosis as controls was conducted. dual energy x-ray absorptiometry (dxa) was used to determine bone mass density (bmd) of participants and t-scoring was applied to establish whether the patient has osteoporosis or not. serum tgf-β1 and il-18 levels were measured by quantitative sandwich enzyme linked immunosorbent assay (elisa). results serum tgf-β1 levels were significantly higher in osteoporotic postmenopausal females than non-osteoporotic individuals (23.8 vs. 15.8 ng/ml; p = 0.009). there was no difference between il-18 levels in the sera of osteoporotic and non-osteoporotic postmenopausal females in this study. there was a positive correlation between body mass index (bmi) and serum level of tgf-β1 (p = 0.04).

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Transforming Growth Factor β1 (TGF-β1) in the Sera of Postmenopausal Osteoporotic Females

BACKGROUND Postmenopausal osteoporosis is a major cause of morbidity in postmenopausal females. Transforming growth factor β1 (TGF-β1) and interleukin 18 (IL-18) play complex roles in normal bone metabolism, and in pathophysiology of postmenopausal osteoporosis. OBJECTIVES The aim of this study was to design an analytic cross sectional study in order to further clarify the role of TGF-β1 and ...

متن کامل

The Transforming Growth Factor-β1 (TGF-β1) Gene Polymorphisms (TGF-β1 T869C and TGF-β1 T29C) and Susceptibility to Postmenopausal Osteoporosis

UNLABELLED The aim of the present study was to integrate all the eligible studies and investigate whether the transforming growth factor-β1 (TGF-β1) gene polymorphisms (TGF-β1 T869C and TGF-β1 T29C) are correlated with postmenopausal osteoporosis (PMOP) risk. PMOP is a common skeletal disease and several genetic factors play an important role in the development and progression of PMOP. Signific...

متن کامل

TGF-β1 (Transforming Growth Factor-β1) Plays a Pivotal Role in Cardiac Myofibroblast Arrhythmogenicity.

BACKGROUND TGF-β1 (transforming growth factor-β1) importantly contributes to cardiac fibrosis by controlling differentiation, migration, and collagen secretion of cardiac myofibroblasts. It is still elusive, however, to which extent TGF-β1 alters the electrophysiological phenotype of myofibroblasts and cardiomyocytes and whether it affects proarrhythmic myofibroblast-cardiomyocyte crosstalk obs...

متن کامل

Suppression of Latent Transforming Growth Factor (TGF)-β1 Restores Growth Inhibitory TGF-β Signaling through microRNAs

Cancer cells secreting excess latent TGF-β are often resistant to TGF-β induced growth inhibition. We observed that RNAi against TGF-β1 led to apoptotic death in such cell lines with features that were, paradoxically, reminiscent of TGF-β signaling activity and that included transiently enhanced SMAD2 and AKT phosphorylation. A comprehensive search in Hela cells for potential microRNA drivers o...

متن کامل

Transforming growth factor-β1 in plaque morphea

INTRODUCTION Morphea (localized scleroderma) is a rare cutaneous disease characterized by skin fibrosis of unknown pathogenesis. Transforming growth factor-β (TGF-β) is a potent profibrotic factor. The role of TGF-β in morphea remains unclear. AIM The goal of this study was to estimate the expression level of TGF-β1 in skin and peripheral blood mononuclear cells as well as the plasma levels o...

متن کامل

بررسی ارتباط پلی‌مورفیسم (C29T (Pro10Leu ژن Transforming Growth Factor βeta1 (TGF-β1) و ناباروری با علت نامشخص در ایران

Abstract: Background and Aim: The increasing incidence of infertility is alarming. About 10-30% of infertility are classified as Unexplained Infertility (UI) which is not an absolute clinical condition. TGF-b1 is multifunctional cytokine and produced mainly by T regulatory (Treg) lymphocytes. This cytokine plays important roles in physiology of normal pregnancy. The association of Single...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
international journal of endocrinology and metabolism

جلد ۱۴، شماره ۴، صفحات ۰-۰

کلمات کلیدی
[ ' t g f ' , ' β 1 ' , ' i l ' , 1 8 , ' o s t e o p o r o s i s ' , ' p o s t m e n o p a u s a l ' ]

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023